Association Between Prediabetes/Diabetes and Asthma Exacerbations in a Claims-Based Obese Asthma Cohort.

[1]  Professional Practice Committee: Standards of Medical Care in Diabetes—2022 , 2021, Diabetes Care.

[2]  M. Szklo,et al.  Severe asthma is associated with metabolic syndrome in Brazilian adolescents. , 2018, The Journal of allergy and clinical immunology.

[3]  Positive predictive value between medical-chart body-mass-index category and obesity versus codes in a claims-data warehouse , 2018, Current medical research and opinion.

[4]  E. Forno,et al.  Obesity and asthma , 2018, The Journal of allergy and clinical immunology.

[5]  C. Cannon,et al.  Professional Practice Committee: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[6]  J. Bates,et al.  An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and Disease , 2017, Annals of the American Thoracic Society.

[7]  R. Suruki,et al.  The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA , 2017, BMC Pulmonary Medicine.

[8]  E. Bleecker,et al.  Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations , 2016, American journal of respiratory and critical care medicine.

[9]  S. Erickson,et al.  Metformin use and asthma outcomes among patients with concurrent asthma and diabetes , 2016, Respirology.

[10]  J. Fahy,et al.  Metabolic consequences of obesity as an “outside in” mechanism of disease severity in asthma , 2016, European Respiratory Journal.

[11]  E. Bleecker,et al.  Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. , 2016, The Lancet. Respiratory medicine.

[12]  M. Gladwin,et al.  Metabolic Syndrome and the Lung. , 2016, Chest.

[13]  A. Dixon,et al.  Mechanisms of Asthma in Obesity. Pleiotropic Aspects of Obesity Produce Distinct Asthma Phenotypes. , 2016, American journal of respiratory cell and molecular biology.

[14]  E. Israel,et al.  Insulin resistance modifies the association between obesity and current asthma in adults , 2016, European Respiratory Journal.

[15]  David Price,et al.  Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice , 2016, Journal of asthma and allergy.

[16]  W. Shrank,et al.  Validity of a Claims-Based Diagnosis of Obesity Among Medicare Beneficiaries , 2015, Evaluation & the health professions.

[17]  M. Desarno,et al.  A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity , 2015, Respiratory Research.

[18]  J. Celedón,et al.  Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma. , 2015, The Journal of allergy and clinical immunology.

[19]  D. Khatry,et al.  High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. , 2014, The journal of allergy and clinical immunology. In practice.

[20]  A. Fryer,et al.  Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats. , 2014, American journal of respiratory cell and molecular biology.

[21]  L. Zuo,et al.  Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma. , 2013, Molecular immunology.

[22]  A. Sood,et al.  Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies , 2013, Journal of allergy.

[23]  Diane Lacaille,et al.  Systematic Review and Meta-Analysis of Validation Studies on a Diabetes Case Definition from Health Administrative Records , 2013, PloS one.

[24]  Hua Xu,et al.  Research and applications: ICD-9 tobacco use codes are effective identifiers of smoking status , 2013, J. Am. Medical Informatics Assoc..

[25]  H. Boushey,et al.  Asthma outcomes: exacerbations. , 2012, The Journal of allergy and clinical immunology.

[26]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[27]  M. Rewers,et al.  A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors , 2010, Diabetes Care.

[28]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[29]  E. Baker,et al.  Hyperglycemia, Lung Infection, and Inflammation , 2009 .

[30]  T. Tran,et al.  Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. , 2009, American journal of respiratory cell and molecular biology.

[31]  J. A. Nogueira-Machado,et al.  From hyperglycemia to AGE-RAGE interaction on the cell surface: A dangerous metabolic route for diabetic patients , 2008 .

[32]  J. A. Nogueira-Machado,et al.  From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients. , 2008, Expert opinion on therapeutic targets.

[33]  David M. Adamson,et al.  HealtH ReseaRcH Data foR tHe Real WoRlD: tHe MaRketscan ® Databases , 2008 .

[34]  E. Kasasbeh,et al.  Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex--a hypothetical review. , 2007, Sleep medicine reviews.

[35]  J. Lau,et al.  Meta-Analysis: Efficacy and Safety of Inhaled Insulin Therapy in Adults with Diabetes Mellitus , 2006, Annals of Internal Medicine.

[36]  M. Huber,et al.  Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway. , 2006, Experimental hematology.

[37]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[38]  W. Greene,et al.  Accounting for Excess Zeros and Sample Selection in Poisson and Negative Binomial Regression Models , 1994 .

[39]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.